Navigation Links
New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders

d interferon and ribavirin. Only 7 of the 57 patients entering the study dropped out prior to week 12.

Under the terms of the Agreement, Schering supplied PEGETRON(TM) (peginterferon alfa-2b powder for solution plus ribavirin 200 mg capsules) as well as certain technical and laboratory support and other services for MIGENIX's celgosivir Phase II combination study in chronic HCV patients and a related extension protocol. In addition, the Agreement granted Schering limited periods of exclusivity for data review of clinical trial results and for the negotiation of a license agreement. With the new top-line results, we will be working to provide a data package to Schering over the next few weeks, after which Schering's limited period of exclusivity for data review under the Agreement will commence. No license terms have been negotiated with Schering to date.

Celgosivir is an alpha-glucosidase I inhibitor and is currently the only anti-HCV drug in clinical development that acts on host-directed glycosylation. In preclinical studies, celgosivir has shown excellent in vitro synergy with various interferons in the clinic or in development including Pegasys, PEG-Intron, Infergen, Alferon and IFN-omega (with or without ribavirin) and other drugs in development for the treatment of HCV (e.g. polymerase inhibitors) and therefore has the potential to be included as part of many combination therapeutic approaches to improve efficacy in anti-HCV therapy.

HCV, the most common chronic blood-borne infection in the United States, causes inflammation of the liver and may progress to more serious complications such as cirrhosis of the liver, liver cancer and death. Approximately 2.7 million people in the United States are chronically infected with HCV, and the Centers for Disease Control and Prevention (CDC) estimates that by the year 2010, the number of deaths attributed annually to HCV could surpass that due to HIV/AIDS in the US. Worldwide, the World Health Organ
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:8/27/2014)... , Aug. 27, 2014 /PRNewswire/ ... market research report is available in ... Guidebook for Application and Approval of ... to Practices (2014 Edition) ... Now, Chinese regulations on ...
(Date:8/27/2014)... R.I. , Aug. 27, 2014  CVS Caremark ... entered into a new clinical affiliation with MedStar Health, ... Maryland and the ... to high-quality, affordable health care services for patients. Through ... have access to clinical support, medication counseling, chronic disease ...
(Date:8/27/2014)... , Aug. 27, 2014 Amgen (NASDAQ: ... and Drug Administration (FDA) has granted priority review designation ... (HF). Ivabradine is an oral drug that inhibits the ... the sinoatrial node, the body,s cardiac pacemaker. 1 ... effects on myocardial contractility or ventricular repolarization. 1 ...
Breaking Medicine Technology:Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 2FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 4FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 5FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 6FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 7
... Inc. (NASDAQ - YDNT) today announced that it will broadcast ... web cast conference call on Thursday, October 20, 2011 at ... call will be available through InterCall at http://tinyurl.com/YI-Quarter32011 . ... through the Company,s website, www.ydnt.com . ...
... CEO Yaacov Shoham today announced the following order. ... many new markets, including Australia-a most important market for IDenta,s ... 2000 detectors from the Australian representative GK Solutions Pty ... several months we have been in continuous contact with this ...
Cached Medicine Technology:Young Innovations, Inc. Provides 3rd Quarter Conference Call Details 2International Drug & Explosives Detection Company IDenta Corp. Receives Order From Australia 2
(Date:8/27/2014)... (PDT, which uses topical agents and light to kill ... common skin lesion caused by sun damage) at three ... to freeze lesions). , Author: Gayatri Patel, ... Center, in Sacramento, and colleagues. , Background: ... found on individuals with fair complexions who have had ...
(Date:8/27/2014)... Michigan Head & Neck Institute is hosting a school supplies ... by ensuring they have everything they need for a wonderful ... Head & Neck Institute wants to ensure the children are ... are a lot of military families in the area, and ... to our community," said Lauren Taylor, Marketing Coordinator at Michigan ...
(Date:8/27/2014)... 2014 Dr. Stewart Shofner ... multitudes of patients suffering from impaired vision. Some of ... vision correction surgery . Recently, Dr. Shofner has noticed ... an eye exam and also online. To help patients ... myths about glaucoma. , 1)    Myth: People with perfect vision ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Parker Waichman ... the rights of victims injured by defective medical devices, ... place for discovery procedures, specifically Collection and Preservation of ... Bard’s transvaginal mesh devices. (MDL No. 2187, In Re: ... the United States District Court, Southern District or West ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Ticket Down is ... at Sun Life Stadium in Miami. The Brazilian ... team on September 5 at Sun Life Stadium in Miami ... in a rematch of the World Cup earlier this year ... Neymar to injury. The Brazilian Soccer Federation announced earlier this ...
Breaking Medicine News(10 mins):Health News:Photodynamic therapy vs. cryotherapy for actinic keratoses 2Health News:Michigan Head & Neck Institute is Conducting Their 2nd Annual School Supplies Drive at Their Facility to Benefit Local Year-Round Elementary School Students 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 4Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 2Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 4Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 3
... NEWTOWN, Pa., Oct. 21 Steaz, the nation,s premier ... Calorie Sparkling Green Tea -- the first certified organic, ... http://www.newscom.com/cgi-bin/prnh/20091021/LA96159 ) , Steaz Zero Calorie is a delicious, ... with the finest organic ingredients and sweetened with the ...
... Schein, Inc. (Nasdaq: HSIC ) announced today that it ... stock market opens on Wednesday, November 4, 2009, and will ... the same day beginning at 10 a.m. Eastern Standard Time. ... Chairman and Chief Executive Officer of Henry Schein, and Steven ...
... For a sample of prevention awareness ... one is suggested to start on: BRCA; DHEA; Estradiol; ... D. , Some will be covered by Dr. Khalid Mahmud ... Oncologist View of Hormones and Breast Cancer: How to Safely ...
... ... to announce that it has made another significant commitment to environmental sustainability by joining ... are engaged in reducing their environmental footprints. , ... Irvine, CA (PRWEB) October 21, 2009 -- Vestara, provider ...
... ... ranging from gluten intolerance to celiac disease. , ... Springfield, MA (PRWEB) October 21, 2009 -- A newly-opened online store ... disease and gluten intolerance. This medical problem can show up at any age, and ...
... ... in every county in every state. This year,s survey indicates that medical malpractice insurance ... ... -- Rates for physicians, 2009-2010 liability insurance premiums decreased or remained stable for the ...
Cached Medicine News:Health News:Steaz Launches Organic, Zero Calorie Sparkling Line 2Health News:Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday, November 4, at 10 A.M. EST 2Health News:Bioidentical Hormones, a True Prevention for Breast Cancer 2Health News:Vestara Joins National Health Organization Practice Greenhealth to Further Support Environmental Practices 2Health News:Vestara Joins National Health Organization Practice Greenhealth to Further Support Environmental Practices 3Health News:Gluten Free Superstore Opens With 4,000 Products 2Health News:Medical Liability Monitor Annual Survey of Medical Malpractice Insurance Rates Shows Medical Liability Insurance Market Remains Soft 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: